SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-011154
Filing Date
2023-04-26
Accepted
2023-04-26 16:30:46
Documents
13
Period of Report
2023-04-25
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K zvra20230426_8k.htm   iXBRL 8-K 45585
  Complete submission text file 0001437749-23-011154.txt   182824

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA zvra-20230425.xsd EX-101.SCH 3601
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zvra-20230425_def.xml EX-101.DEF 11919
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE zvra-20230425_lab.xml EX-101.LAB 15966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zvra-20230425_pre.xml EX-101.PRE 12130
7 EXTRACTED XBRL INSTANCE DOCUMENT zvra20230426_8k_htm.xml XML 2661
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 23850208
SIC: 2834 Pharmaceutical Preparations